|
Synonyms: CDD3155 | compound 40 [Ku et al., 2026]
Compound class:
Synthetic organic
Comment: CDD-3155 is a selective serine/threonine kinase 33 (STK33) inhibitor [1-2]. It is proposed as a chemical tool to progress the development of STK33 inhibitors for use as nonhormonal male contraceptives.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Ku AF, Ta HM, Wang Y, Kaown G, Sharma KL, Bohren KM, Qin X, Wang J, Jimmidi P, Madasu C et al.. (2026)
Design, Synthesis, and Pharmacological Profiling of Serine/Threonine Kinase 33 (STK33) Inhibitors for Nonhormonal Male Contraception. J Med Chem, Epub ahead of print. DOI: 10.1021/acs.jmedchem.6c00790 |
|
2. Matzuk M, Ku A, Sharma K, Bohren K, Kim C, Chamakuri S, Wang Y, Li F, Teng M, Madasu C et al.. (2025)
Inhibitors of stk33, ret, clk, and/or related kinases and methods using same. Patent number: WO2025106722A1. Assignee: Baylor College of Medicine. Priority date: 14/11/2024. Publication date: 22/05/2025. |